NasoShield (anthrax intranasal vaccine) / Altimmune  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NasoShield (anthrax intranasal vaccine) / Altimmune
NasoShield, NCT03352466: Study of Safety and Immunogenicity

Unknown status
1
145
US
NasoShield, BioThrax, Placebo
Altimmune, Inc.
Healthy Volunteers
08/18
08/19
NCT04415749: NasoShield in Healthy Adults to Study Safety and Immunogenicity

Completed
1
42
US
NasoShield, Placebo
Altimmune, Inc., Biomedical Advanced Research and Development Authority
Healthy Volunteers
03/21
03/21

Download Options